82. Regarding biosimilar products, which of the following is true? a. Biosimilars are almost always extracted from natural products. b. Biosimilars are identical to the brand-name product. c. Due to economies of scale, biosimilars are always sub- stantially less expensive than the brand-name product. d. Biosimilars are required to be comparable to the prede- cessor product. 83. Which of the following statements are true? a. Prescribers must always demand the use of a generic medication. b. In practice, the use of generics is common when appro- priate. c. Generic substitution is governed by federal law. d. In many cases, patient preference for brand-name or ge- neric medications can be overruled by the pharmacist. 84. Which of the following statements is true? a. The exclusive use of brand-name medications is relative- ly expensive. b. It has been acknowledged that there is a need for cost-ef- fective alternatives to brand-name products. c. The use of generics has led to some cases of controversy. d. All of the above are true. 85. Which of the following arguments have been used to op- pose the use of generic medications? a. Generic drug products lead to competitive pricing. b. There have been instances of inferior generic drug qual- ity. c. Arguments have been recently proven that FDA officials received bribes to loosen bioequivalence guidelines. d. Evidence of consistent safety issues with generic medica- tions have been confirmed.
Course Code: RPTX01DC
Page 107
Book Code: RPTX3024
EliteLearning.com/Pharmacy
Powered by FlippingBook